These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 37088469)

  • 1. Clinical significance of long non-coding RNA ZEB2-AS1 and EMT-related markers in ductal and lobular breast cancer.
    Zarei M; Malekzadeh K; Omidi M; Mousavi P
    Cancer Rep (Hoboken); 2023 May; 6(5):e1826. PubMed ID: 37088469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA ZEB2-AS1 expression is associated with disease progression and predicts outcome in gastric cancer patients.
    Xu C; Cui H; Li H; Wu Y; An H; Guo C
    J BUON; 2019; 24(2):663-671. PubMed ID: 31128021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA ZEB2-AS1 promotes the proliferation, metastasis and epithelial mesenchymal transition in triple-negative breast cancer by epigenetically activating ZEB2.
    Zhang G; Li H; Sun R; Li P; Yang Z; Liu Y; Wang Z; Yang Y; Yin C
    J Cell Mol Med; 2019 May; 23(5):3271-3279. PubMed ID: 30825262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of ZEB2-AS1 promotes epithelial-to-mesenchymal transition and metastasis by stabilizing ZEB2 mRNA in head neck squamous cell carcinoma.
    Diao P; Ge H; Song Y; Wu Y; Li J; Li Z; Yang J; Wang Y; Cheng J
    J Cell Mol Med; 2019 Jun; 23(6):4269-4280. PubMed ID: 30950191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role and clinical significance of long noncoding RNA zinc finger E-box-binding homeobox two antisense RNA 1 in promoting osteosarcoma cancer cell proliferation, inhibiting apoptosis and increasing migration by regulating miR-145.
    Zhou Y; Feng D; Gu X; Gao A; Liu Y
    Anticancer Drugs; 2021 Feb; 32(2):168-177. PubMed ID: 32826416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Long Noncoding RNA ZEB2-AS1 Contributes to Proliferation and Epithelial-to-Mesenchymal Transition of Osteosarcoma.
    Yang J; Zou Y; Wu J; Chen B; Luo C; Chen X; Shen H; Luo L
    Cancer Biother Radiopharm; 2023 Nov; 38(9):596-603. PubMed ID: 33085924
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristics and transcriptional regulators of spontaneous epithelial-mesenchymal transition in genetically unperturbed patient-derived non-spindled breast carcinoma.
    Lien HC; Yu HC; Yu WH; Lin SF; Chen TW; Chen IC; Hsiao LP; Yeh LC; Li YC; Lo C; Lu YS
    Breast Cancer Res; 2024 Sep; 26(1):130. PubMed ID: 39256881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).
    He R; Zhang FH; Shen N
    Biomed Pharmacother; 2017 Nov; 95():331-338. PubMed ID: 28858731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA ZEB2-AS1 contributes to the tumorigenesis of gastric cancer via activating the Wnt/β-catenin pathway.
    Wang F; Zhu W; Yang R; Xie W; Wang D
    Mol Cell Biochem; 2019 Jun; 456(1-2):73-83. PubMed ID: 30635820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of ZEB2-AS1 inhibits cell invasion and induces apoptosis in colorectal cancer.
    Wu X; Zhu H; Xie Y; Gu X; Zhang L; Huang L
    J BUON; 2020; 25(1):194-201. PubMed ID: 32277632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LBX2-AS1 is activated by ZEB1 and promotes the development of esophageal squamous cell carcinoma by interacting with HNRNPC to enhance the stability of ZEB1 and ZEB2 mRNAs.
    Zhang Y; Chen W; Pan T; Wang H; Zhang Y; Li C
    Biochem Biophys Res Commun; 2019 Apr; 511(3):566-572. PubMed ID: 30824187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect and mechanism of long non-coding RNA ZEB2-AS1 in the occurrence and development of colon cancer.
    Guo X; Jing YM; Lou HZ; Lou QA
    Math Biosci Eng; 2019 Sep; 16(6):8109-8120. PubMed ID: 31698657
    [No Abstract]   [Full Text] [Related]  

  • 13. Knockdown of lncRNA ZEB2NAT suppresses epithelial mesenchymal transition, metastasis and proliferation in breast cancer cells.
    Eroğlu Güneş C; Güçlü E; Vural H; Kurar E
    Gene; 2021 Dec; 805():145904. PubMed ID: 34418470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
    Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
    Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
    [No Abstract]   [Full Text] [Related]  

  • 15. [
    Zhang RH; Huang JP; Li JW; Li YQ; Cui XY; Xiong YN; Liu YK; Zhang GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 May; 54(3):558-564. PubMed ID: 37248584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lnc NR2F1-AS1 Promotes Breast Cancer Metastasis by Targeting the MiR-25-3p/ZEB2 Axis.
    Zhai D; Zhou Y; Kuang X; Shao F; Zhen T; Lin Y; Wang Q; Shao N
    Int J Med Sci; 2023; 20(9):1152-1162. PubMed ID: 37575267
    [No Abstract]   [Full Text] [Related]  

  • 17. lncRNA ZEB2-AS1: A promising biomarker in human cancers.
    Mahboobeh Z; Pegah M; Fatemeh S; Elham K; Hanieh A; Milad R; Mohammad S
    IUBMB Life; 2020 Sep; 72(9):1891-1899. PubMed ID: 32687675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA XIST promotes TGF-β-induced epithelial-mesenchymal transition by regulating miR-367/141-ZEB2 axis in non-small-cell lung cancer.
    Li C; Wan L; Liu Z; Xu G; Wang S; Su Z; Zhang Y; Zhang C; Liu X; Lei Z; Zhang HT
    Cancer Lett; 2018 Apr; 418():185-195. PubMed ID: 29339211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA TP73-AS1 predicts the prognosis of bladder cancer patients and functions as a suppressor for bladder cancer by EMT pathway.
    Tuo Z; Zhang J; Xue W
    Biochem Biophys Res Commun; 2018 May; 499(4):875-881. PubMed ID: 29625110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA ZEB2-AS1 promotes bladder cancer cell proliferation and inhibits apoptosis by regulating miR-27b.
    Wu X; Yan T; Wang Z; Wu X; Cao G; Zhang C
    Biomed Pharmacother; 2017 Dec; 96():299-304. PubMed ID: 28992472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.